Litigation

Recent Posts

California High Court: Pharmacies That 'Passed On' Higher Costs Have UCL Injury
Posted on 12 Jul 2010 by Bryan Redding

SAN FRANCISCO - (Mealey's) Pharmacies have standing to pursue unfair competition law (UCL) claims alleging that they paid higher prices because of price fixing by pharmaceutical companies, even though they passed the higher prices on to consumers... Read More

Tags: pharmacies , Eli Lilly & Co. , Hanover Shoe v. United Shoe Mach , Johnson & Johnson Health Care Systems Inc. , Boehringer Ingelheim Pharmaceuticals , pharmaceutical companies , Pharmaceutical Research and Manufacturers of America , James Clayworth , Abbott Laboratories , Pfizer Inc. , Wyeth Pharmaceuticals , California , UCL , Amgen Inc. , Allergan Inc. , Illinois Brick Co. v. Illinois , Business and Professions Code , price fixing , Cartwright Act , unfair competition law , AstraZeneca International , California Supreme Court , Novartis Pharmaceuticals Corp. , Hoffman-LaRoche Inc. , Litigation , lawsuit , Merck & Co. , Bristol-Myers Squibb Co.

Boehringer Ingelheim Pays $95 Million To Settle Off-Label, Kickback Claims In Civil Suit
Posted on 27 Oct 2012 by Tom Moylan

BALTIMORE — Boehringer Ingelheim Pharmaceuticals Inc. will pay $95 million to the federal government to resolve civil allegations that it marketed three drugs for off-label uses, promoted high doses of two drugs and paid kickbacks to health care... Read More

Tags: off-label uses , False Claims Act , Boehringer Ingelheim Pharmaceuticals , Abbott Laboratories , chronic obstructive pulmonary disease , Micardis , COPD , Atrovent , Robert Heiden , hypertension , Aggrenox , bronchospasm , Medicaid , Litigation , lawsuit , Settlement , United States of American v. Boehringer Ingelheim , Combivent , kickbacks